US4780320A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Controlled release drug delivery system for the periodontal pocket
Assignee: PHARMETRIX Inc
•
Filing: 1986-04-29
•
Granted: 1988-10-25
•
Expires: 2006-04-29
Abstract
Abstract A controlled release drug delivery system for placement in the periodontal pocket. The system comprises a plurality of drug-containing microparticles or microcapsules, between 10 and 500 microns in size, suspended in a pharmaceutically acceptable carrier medium, and is capable of maintaining an effective level of drug in the periodontal pocket for a period of 1 to 30 days.
Inventors
- 👤 Richard W. Baker
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 03:13
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1652; A61K6/00; A61K6/15; A61K6/17; A61K6/30; A61K6/60; A61K6/69; A61K9/0012; A61K9/0053; A61K9/0063; A61K9/1641; A61K9/1647
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
66 words
A controlled release drug delivery system for placement in a periodontal pocket, comprising: (a) a plurality of discrete microparticles comprising a drug-containing polymer and the drug contained therein, said microparticles being between 10 and 500 microns in diameter, and (b) a fluid suspending medium for said microparticles; said drug delivery system remaining active in the periodontal pocket for a period of between one and 30 days.
Claim 2
Dependent Claim
66 words
A controlled release drug delivery system for placement in a periodontal pocket, comprising: (a) a plurality of discrete microparticles comprising a drug-containing polymer and the drug contained therein, said microparticles being between 10 and 500 microns in diameter, and (b) a fluid suspending medium for said microparticles; said drug delivery system remaining active in the periodontal pocket for a period of between one and 30 days.
Claim 3
Dependent Claim
23 words
The delivery system of claim 1, wherein the drug is selected from the group consisting of antimicrobial drugs, anti-inflammatory drugs and local anaesthetics.
Claim 4
Dependent Claim
12 words
The delivery system of claim 1, wherein the drug is an antibiotic.
Claim 5
Dependent Claim
21 words
The delivery system of claim 1, wherein the drug is chosen from the group consisting of tetracycline, its compounds and derivatives.
Claim 6
Dependent Claim
21 words
The delivery system of claim 1, wherein the drug is chosen from the group consisting of chlorhexidine, its compounds and derivatives.
Claim 7
Dependent Claim
11 words
The delivery system of claim 1, wherein the drug is flurbiprofen.
Claim 8
Dependent Claim
27 words
The delivery system of claim 1, wherein said drug-containing polymer is chosen from the group consisting of cellulose acetate, ethylcellulose, polystyrene, polysulfone, polycarbonate and lacticglycolic acid copolymers.
Claim 9
Dependent Claim
12 words
The delivery system of claim 1, wherein said drug-containing polymer is polycarbonate.
Claim 10
Dependent Claim
20 words
The delivery system of claim 1, wherein said drug-containing polymer is chosen from the group consisting of lacticglycolic acid copolymers.
Claim 11
Dependent Claim
19 words
The delivery system of claim 1, wherein the fluid suspending medium has a viscosity of at least 1000 centipoise.
Claim 12
Dependent Claim
46 words
The delivery system of claim 1, wherein the fluid suspending medium is a thermally gelling fluid, said fluid having a sol/gel transition temperature between 25° and 40° C. and being a free-flowing liquid below the transition temperature and a thickened non-flowing gel above the transition temperature.
Claim 13
Independent Claim
72 words
A method for treating periodontal disease comprising inserting into a periodontal pocket a controlled release drug delivery system comprising: (a) a plurality of discrete microparticles comprising a drug-containing polymer and the drug contained therein, said microparticles being between 10 and 500 microns in diameter, and (b) a fluid suspending medium for said microparticles; said drug delivery system remaining active in the periodontal pocket for a period of between one and 30 days.
Claim 14
Independent Claim
72 words
A method for treating periodontal disease comprising inserting into a periodontal pocket a controlled release drug delivery system comprising: (a) a plurality of discrete microparticles comprising a drug-containing polymer and the drug contained therein, said microparticles being between 10 and 500 microns in diameter, and (b) a fluid suspending medium for said microparticles; said drug delivery system remaining active in the periodontal pocket for a period of between one and 30 days.
References Cited (Backward Citations)
US3185625A
Cited
US4039653A
Cited
US4059686A
Cited
US3972995A
Cited
US4585651A
Cited
US4226848A
Cited
US4250163A
Cited
US4622244A
Cited
US4369172A
Cited
US4434153A
Cited
US4568535A
Cited
US4597960A
Cited
US4569837A
Cited
US4652441A
Cited
US4568536A
Cited
US4650665A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-10-25 | 1992-04-25 | 1992-10-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-10-25 | 1996-04-25 | 1996-10-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-10-25 | 2000-04-25 | 2000-10-25 | $7700.00 | Window Closed / Lapsed |